向下滑动查看参考文献
[1]Tang, S.W.; Leonard, B.E.; Helmeste, D.M. Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatr. 2022, 34, 109–126.
[2]Tansey, C.M.; Louie, M.; Loeb, M.; Gold, W.L.; Muller, M.P.; de Jager, J.; Cameron, J.I.; Tomlinson, G.; Mazzulli, T.; Walmsley, S.L.; et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 2007, 167, 1312–1320.
[3]Son, G.; Jahanshahi, A.; Yoo, S.J.; Boonstra, J.T.; Hopkins, D.A.; Steinbusch, H.W.M.; Moon, C. Olfactory neuropathology in Alzheimer’s disease: A sign of ongoing neurodegeneration. BMB Rep. 2021, 54, 295–304.
Ritchie, K.; Chan, D. The emergence of cognitive COVID. World Psychiatry 2021, 20, 52–53.
[4]Boldrini, M.; Canoll, P.D.; Klein, R.S. How COVID-19 Affects the Brain. JAMA Psychiatry 2021, 78, 682–683.
[5]使用医院抑郁与焦虑量表:Matsumoto, K.; Hamatani, S.; Shimizu, E.; Käll, A.; Andersson, G. Impact of post-COVID conditions on mental health: A cross-sectional study in Japan and Sweden. BMC Psychiatry 2022, 22, 237.
使用PHQ-9:Strahm, C.; Seneghini, M.; Güsewell, S.; Egger, T.; Leal, O.; Brucher, A.; Lemmenmeier, E.; Kleeb, D.M.; Möller, J.C.; Rieder, P.; et al. Symptoms Compatible with Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort. Clin. Infect. Dis. 2022, 75, e1011–e1019.
使用GAD-7:Chen, A.K.; Wang, X.; McCluskey, L.P.; Morgan, J.C.; Switzer, J.A.; Mehta, R.; Tingen, M.; Su, S.; Harris, R.A.; Hess, D.C.; et al. Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA. Brain Behav. Immun. Health 2022, 24, 100491.
相关康复指导(初代):
Serrano-Castro, P.J.; Estivill-Torrús, G.; Cabezudo-García, P.; Reyes-Bueno, J.A.; Ciano Petersen, N.; Aguilar-Castillo, M.J.; Suárez-Pérez, J.; Jiménez-Hernández, M.D.; Moya-Molina, M.Á.; Oliver-Martos, B.; et al. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? Neurologia 2020, 35, 245–251.
Barker-Davies, R.M.; O’Sullivan, O.; Senaratne, K.P.P.; Baker, P.; Cranley, M.; Dharm-Datta, S.; Ellis, H.; Goodall, D.; Gough, M.; Lewis, S.; et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br. J. Sports Med. 2020, 54, 949–959.
Soh, H.L.; Ho, R.C.; Ho, C.S.; Tam, W.W. Efficacy of digital cognitive behavioural therapy for insomnia: A meta-analysis of randomised controlled trials. Sleep Med. 2020, 75, 315–325.
Reynolds, C.F. Optimizing personalized management of depression: The importance of real-world contexts and the need for a new convergence paradigm in mental health. World Psychiatry 2020, 19, 266–268.